Tanarra Capital

OXECO is a chemistry technology firm that creates, engineers, and manufactures specialty chemicals for the clean technology and transportation industries. Using cutting-edge carbene technology, the company's revolutionary ONTOTM technology platform governs how surfaces behave.

Health Metrics is a prominent provider of software solutions tailored for the aged care sector. The company develops comprehensive software designed for residential aged care, home care, and independent living units. Its platform features a clinical and administrative system that includes tools for customer relationship management (CRM), Medicare online claiming, clinical care, electronic rostering, electronic contracts, quality management, medication management, and virtual telehealth integration. These solutions enable clients to manage their clinics effectively and enhance operational efficiency.

August Robotics specializes in developing application-specific robots aimed at automating labor-intensive workflows within the B2B sector. The company has introduced its first two robots: Lionel, which streamlines the floor-marking process for the global exhibition industry, and Diego, which focuses on disinfecting high-traffic public spaces like hotels and offices to enhance hygiene and minimize infection risks. By leveraging its proprietary mobile robotics platform, August Robotics can rapidly create new robot models tailored to various tasks. The company's mission is to transform the physical workplace by optimizing efficiency, reliability, and safety in collaboration with human workers, ultimately improving business workflows across diverse industries.

Fraction is a technology company that provides a fractional ownership infrastructure on an internet-scale. Users can invest in, sell, and manage fractional ownership of anything using its plug-and-play platform. Its products enable fractional ownership for real estate developers, small and medium-sized businesses, investment funds and pooled capital, and everything in between.

INX Software provides integrated workforce management software across safety, logistics, compliance, risk, training and competence, stakeholders, environment, management of change and occupational health and hygiene all from the one central database. Our solutions drive efficiencies, reduce risks, and increase compliance for our customers. Our proven and robust solution is used by over 500,000 people in over 23 countries worldwide.

Genomics plc is focused on transforming healthcare through advanced genomic analysis. The company employs sophisticated methodologies to analyze large integrated datasets of genomic and phenotypic information, aiming to enhance understanding of human biology. By leveraging genetic inference technology, Genomics plc seeks to identify new drug targets for serious diseases and assess individual disease risk. Their analytical platform enables the exploration of genomic sequence data, providing valuable insights that support pharmaceutical companies in reducing risks associated with drug development. This approach not only aims to improve healthcare outcomes but also sets a standard for how organizations and patients can benefit from genomic data.

Animal Dynamics specializes in developing advanced robotics and systems inspired by the principles of evolutionary biomechanics. The company leverages recent advancements in analytical technology to conduct in-depth studies of high-performance animals, allowing for a nuanced understanding of their efficient and powerful designs. By integrating fine engineering with insights from nature, Animal Dynamics creates innovative robotic vehicles capable of superior performance across various applications, including crop spraying, surveying, fire suppression, and humanitarian aid. This approach not only aims to replicate nature's designs but also to enhance them through the use of cutting-edge materials science, microelectronics, and software engineering, ultimately striving to deliver solutions that are both effective and environmentally conscious.

Genomics plc is focused on transforming healthcare through advanced genomic analysis. The company employs sophisticated methodologies to analyze large integrated datasets of genomic and phenotypic information, aiming to enhance understanding of human biology. By leveraging genetic inference technology, Genomics plc seeks to identify new drug targets for serious diseases and assess individual disease risk. Their analytical platform enables the exploration of genomic sequence data, providing valuable insights that support pharmaceutical companies in reducing risks associated with drug development. This approach not only aims to improve healthcare outcomes but also sets a standard for how organizations and patients can benefit from genomic data.

August Robotics specializes in developing application-specific robots aimed at automating labor-intensive workflows within the B2B sector. The company has introduced its first two robots: Lionel, which streamlines the floor-marking process for the global exhibition industry, and Diego, which focuses on disinfecting high-traffic public spaces like hotels and offices to enhance hygiene and minimize infection risks. By leveraging its proprietary mobile robotics platform, August Robotics can rapidly create new robot models tailored to various tasks. The company's mission is to transform the physical workplace by optimizing efficiency, reliability, and safety in collaboration with human workers, ultimately improving business workflows across diverse industries.

Arctoris Limited is a biotechnology company based in Oxford, United Kingdom, with additional operations in Boston and Singapore. Founded in 2016, Arctoris has developed an automated drug discovery platform that combines advanced robotics and data science to facilitate cellular and molecular biology experiments. The platform allows researchers and biotech entrepreneurs to design experiments online and receive detailed results and reports, enhancing their ability to make informed decisions. Arctoris actively engages in drug discovery programs, particularly in oncology and neurology, while also providing access to its platform for select biotech and pharmaceutical partners. By leveraging artificial intelligence and robotics, Arctoris aims to generate high-quality data from various assays, thereby accelerating the progression of drug discovery programs toward clinical application.

They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence. To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.